Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Host organism refers to a living animal or plant that harbors a parasite, commensal, or pathogen, providing it with necessary resources such as nutrients and shelter (Britannica, 2023). In the fields of pharmacology and clinical medicine, the host organism is typically the human patient or an animal model undergoing therapeutic treatment (NIH, 2022). This term is a broad biological classification and does not refer to a specific molecular target, such as a receptor, enzyme, or ion channel. Instead, drugs are designed to interact with specific molecular components within the host or with the pathogens that infect them (Nature Education, 2014). Understanding the physiological and immunological state of the host organism is essential for predicting drug efficacy, metabolism, and potential toxicity (PubMed, 2021). Because it encompasses the entire organism, it is considered a broad biological category rather than a discrete therapeutic target.
Not applicable as this refers to a biological entity rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host organism.